Page 124 - 《中国药房》2023年17期
P. 124

·药师与药学服务·


          基于综合药物管理评价的老年患者药物相关问题的药学服务模
          式探索
                     Δ


                                                                              6
                                                                     5
                                    1
                                             1
                            3
                                                                                      1 #
          龚 辉    1, 2* ,李 晨 ,单 青 ,刘 伟 ,陈 洪 ,赵 氚 ,邹 慧 ,黄转青 ,陈孟莉 (1.中国人民解放军总医
                                                             1
                                                     4
          院医疗保障中心药剂科,北京 100853;2.中国人民解放军总医院研究生院,北京 100853;3.中国人民解放军
          总医院医学创新研究部转化医学中心,北京 100853;4.中国人民解放军第六医学中心干部诊疗科,北京
          100853;5.中国人民解放军总医院京中医疗区门诊部,北京 100853;6.中国人民解放军第944医院眼科,甘肃
          酒泉 735000)
          中图分类号  R969.3      文献标志码  A      文章编号  1001-0408(2023)17-2162-05
          DOI  10.6039/j.issn.1001-0408.2023.17.20

          摘   要  目的  基于综合药物管理评价(CMMR)探索应对老年患者药物相关问题(DRPs)的药学服务模式,并观察该模式下的药
          学服务效果。方法  参考澳大利亚CMMR指南,建立老年患者药学服务新模式:临床药师通过保健医生转诊、患者或其照护者主
          动咨询等途径来接诊;出诊采取面诊和电话访谈相结合的方式;并采取门诊复诊、电话随访、预约上门指导等形式了解保健医生或
          患者对DRPs的处置情况。在该模式下,通过横断面调查老年患者DRPs的发生现状及分类,通过自身前后对照,从住院率、药品
          不良反应(ADR)发生率、用药依从性、用药数量、血脂水平等方面评价药学服务效果。结果  在本研究中,形成了以患者为中心,评
          估-干预-再评估的闭环药学服务模式。调查结果发现,317例研究对象中,有203例(64.0%)发生了DRPs,平均每人发生DRPs 1.03
         (0~7)例次。采用所建立的药学服务模式干预后,与干预前对比,虽然用药数量由2.00(0.00,3.00)种增至2.00(1.00,3.00)种,但
          患者低密度脂蛋白胆固醇水平由 3.48(2.58,4.29) mmol/L 下降至 3.11(2.29,3.81) mmol/L(P<0.05);患者 1 年内住院率、1 年内
          ADR 发生率、用药依从性评分变化无统计学意义(P>0.05)。结论  基于 CMMR 的药学服务模式能有效甄别并管理老年患者的
          DRPs,降低患者血脂水平。
          关键词  药物相关问题;老年患者;综合药物管理评价;药学服务

          Study on pharmaceutical care model for drug-related problems in elderly patients based on comprehensive
          medication management review
                                                    1
                    1, 2
          GONG Hui ,LI Chen ,SHAN Qing ,LIU Wei ,CHEN Hong ,ZHAO Chuan ,ZOU Hui ,HUANG Zhuanqing ,
                                           1
                                                                               1
                                                                                         5
                              3
                                                                 4
                                                                                                            6
                       1
          CHEN Mengli(1.  Dept.  of  Pharmacy,  Medical  Supplies  Centre  of  PLA  General  Hospital,  Beijing  100853,
          China;2.  Graduate  School  of  PLA  General  Hospital,  Beijing  100853,  China;3.  Translational  Medicine  Center,
          Department  of  Medical  Innovation  and  Research,  PLA  General  Hospital,  Beijing  100853,  China;4.  Cadre
          Diagnosis  and  Treatment  Department,  the  Sixth  Medical  Center  of  PLA  General  Hospital,  Beijing  100853,
          China;5. Outpatient Department, Jingzhong Medical District of PLA General Hospital, Beijing 100853, China;
          6. Dept. of Ophthalmology, the 944th Hospital of PLA, Gansu Jiuquan 735000, China)
          ABSTRACT    OBJECTIVE  To  explore  the  pharmaceutical  care  model  for  elderly  patients  with  drug-related  problems (DRPs)
          based on the comprehensive medication management review (CMMR), and to observe the effect of pharmaceutical care under the
          model.  METHODS  The  pharmaceutical  care  new  model  for  elderly  patients  was  established  by  concerning  CMMR  guidelines  in
          Australia.  In  other  words,  clinical  pharmacists  receive  medical  care  through  referral  by  health  practitioners  and  active  consultation
          by  patients  or  their  caregivers. Visits  were  made  by  a  combination  of  face-to-face  and  telephone  interviews.  Follow-up  was  carried
          out  in  the  form  of  outpatient  follow-up,  telephone  follow-up,  appointment,  and  home  guidance  to  know  about  the  treatment  of
                                                              DRPs  by  healthcare  practitioners  or  patients.Under  this  model,
              Δ 基金项目 国家重点研发计划课题(No.2020YFC2005005)            the  occurrence  status  and  classification  of  DRPs  in  elderly
             *第一作者 医师,硕士研究生。研究方向:临床药学。E-mail:
                                                              patients  were  studied  through  cross-sectional  investigation.  The
          gh2017@yeah.net
              # 通信作者 研究员,硕士生导师,博士。研究方向:临床药学、药                 effect of pharmaceutical care was evaluated from the aspects of
          事管理。E-mail:hellolily301cn@126.com                   hospitalization  rate,  adverse  drug  reaction (ADR)  incidence,


          · 2162 ·    China Pharmacy  2023 Vol. 34  No. 17                            中国药房  2023年第34卷第17期
   119   120   121   122   123   124   125   126   127   128   129